1 Result: Nasdaq:TSRO
Diplomat Will Dispense ZEJULA(TM) to Treat Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
April 19th, 2017
The nation’s largest independent specialty pharmacy has been selected to the specialty pharmacy panel to dispense ZEJULA™ (niraparib). FLINT, Mich. / CRWE PRESS RELEASE / April 19, 2017 – Diplomat Pharmacy, Inc. (NYSE: DPLO), ha. Read more
Want To Find Some News?
News By Industries
April 29th, 2017April 28th, 2017April 27th, 2017